Peer Review History

Original SubmissionJuly 12, 2019

Attachments
Attachment
Submitted filename: ResponsetoReviewers.docx
Decision Letter - Xi Chen, Editor

PONE-D-19-19642

The relation between local and distal muscle fat infiltration in chronic whiplash using magnetic resonance imaging

PLOS ONE

Dear Ms Karlsson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Nov 21 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Xi Chen

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

1. Thank you for including your competing interests statement; "We have read the journal's policy and the authors of this manuscript have the following competing interests: TR, MB, and ODL receive salaries and are stockholders of Advanced MR Analytics AB. AK is a stockholder of Advanced MR Analytics AB. This does not alter our adherence to PLOS ONE's policies on sharing data and material."

We note that one or more of the authors received salaries from a commercial company: Advanced MR Analytics AB

  1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the authors for their work in addressing my comments and believe the paper is now much more focused and streamlined. I have a few additional comments and suggestions primarily related to the discussion of the data and conclusions drawn.

1. Introduction: I am still struggling with the connection between this data and the idea of “complementing the neck images with whole body coverage” for diagnostic purposes. First, you are unable to determine whether the stronger correlation between multifidi and lower extremity MFI in the severe WAD group pre-exists and predicts a worse outcome or is a progressive response to injury. The data that you discuss more strongly support the latter, in which case diagnostic whole body scans would not be useful. Second, to argue for whole body scans, you would have to show that the relationship between multifidi and lower extremity MFI is a better indicator than multifidi MFI on its own. This can be grossly assessed by adding the two tests discussed in the next points.

2. Results: Please perform an ANCOVA on your three regressions to determine whether the slopes are significantly different.

3. Results: Please also include an ANOVA on the multifidi MFI between groups to complement Figure 4.

4. Results: Please report all statistical results in your Results section. The Discussion discusses associations between multifidi MFI and age, BMI and duration since injury and a comparison of multifidi MFI across groups. If these are outcomes of the statistical models, please include more details about the models and their outputs so the reader is aware of the results before the discussion.

5. Discussion: Please discuss additional explanations for the association between multifidi and lower extremity MFI. These are mentioned in the Introduction, but I would like to see a more in-depth treatment in the Discussion. “However, a number of hypotheses around injury severity, pain intensity and/or related disability (9, 10), heightened stress-responses (11-13) central/peripheral neuronal interference (14-16), and/or physical inactivity (17, 18) may be offered to explain the rapid expression and larger magnitude of MFI in patients with more severe self-reported symptoms.”

Reviewer #2: Thank you for the opportunity to review this interesting manuscript for PLOS ONE. Our author colleagues have undertaken a study examining the relationship between cervical multifidus MFI and lower limb MFI in controls, mild WAD and mod-severe WAD patients. Findings indicate a relationship between cervical muscle MFI and lower limb MFI in mod-severe WAD patients.

General comments:

This study provides important insight on the mechanisms underpinning chronic WAD, which I believe represents an advance in our knowledge of this challenging condition.

I see that the authors have already made substantial amendments to the manuscript in response to two prior reviewers’ comments. My impression is that they have adequately addressed prior reviewer concerns.

Specific comments:

Abstract

1) “…to investigate the relation between fat infiltration…” awkward wording, suggest revise to ‘…relationship between…’

Introduction

2) Minor typographic error: “…whiplash from an motor vehicle collision.” Correct to ‘…a motor vehicle…’

3) Paragraph 2: “…reporting lower levels of pain-related disability, those nominating full recovery, idiopathic neck pain, and healthy controls.” Suggest add citation to this paper here: Elliott et al. (2008). Fatty infiltrate in the cervical extensor muscles is not a feature of chronic, insidious-onset neck pain. Clin Radiol. 63, 681-687

4) Paragraph 3: In line with the hypothesis around SCI in WAD, I suggest also mentioning the preliminary publication detailing magnetic resonance spectroscopic evidence of cord injury below, as a complementary study supporting this theory:

Elliott JM, Pedler AR, Cowin G, Sterling M, McMahon K. Spinal cord metabolism and muscle water diffusion in whiplash. Spinal Cord. 2012 Jun;50(6):474-6

Methods

5) “…technique uses foreground and backgrounds seeds and let the segmented mask grow.” Awkward wording, suggest revise.

6) “The segmentation was performed by a musculoskeletal physiotherapist with >6 months experience.” Suggest slight re-wording for clarity that it is 6 months experience doing this particular analysis (or as applicable).

7) Statistics: Was there a power/sample size calculation undertaken?

Discussion

8) The Discussion reads well. My only comment is that it would be good to address the contrasting findings between this study and that of Pedler et al (2018) which did not find increased lower limb MFI in WAD:

Pedler A, McMahon K, Galloway G, Durbridge G, Sterling M (2018) Intramuscular fat is present in cervical multifidus but not soleus in patients with chronic whiplash associated disorders. PLoS ONE 13(5): e0197438. https://doi.org/10.1371/journal.pone.0197438

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Plos1_Review_Karlsson.docx
Revision 1

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

- Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

We have adapted the manuscript to PLOS ONE's style requirements.

1. Thank you for including your competing interests statement; "We have read the journal's policy and the authors of this manuscript have the following competing interests: TR, MB, and ODL receive salaries and are stockholders of Advanced MR Analytics AB. AK is a stockholder of Advanced MR Analytics AB. This does not alter our adherence to PLOS ONE's policies on sharing data and material."

We note that one or more of the authors received salaries from a commercial company: Advanced MR Analytics AB

Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

FUNDING STATEMENT

"The study received funding from the Swedish Research Council and the Medical Research Council of South-East Sweden (FORSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, the commercial company AMRA Medical AB provided support in the form of salaries for authors TR, MB and ODL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section."

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

COMPETING INTEREST STATEMENT

We have read the journal's policy and the authors of this manuscript have the following competing interests: TR, MB, and ODL receive salaries and are stockholders of AMRA Medical AB. AK is a stockholder of AMRA Medical AB. This does not alter our adherence to PLOS ONE's policies on sharing data and material.

SPECIFIC COMMENTS TO REVIEWER ARE FOUND IN THE SUPPORTING MATERIAL BUT ALSO CUT IN HERE:

Reviewer #1:

I thank the authors for their work in addressing my comments and believe the paper is now much more focused and streamlined. I have a few additional comments and suggestions primarily related to the discussion of the data and conclusions drawn.

OUR ANSWER: We thank you for once again taking the time to provide insightful comments to further improve our manuscript.

1. Introduction: I am still struggling with the connection between this data and the idea of “complementing the neck images with whole body coverage” for diagnostic purposes. First, you are unable to determine whether the stronger correlation between multifidi and lower extremity MFI in the severe WAD group pre-exists and predicts a worse outcome or is a progressive response to injury. The data that you discuss more strongly support the latter, in which case diagnostic whole-body scans would not be useful. Second, to argue for whole body scans, you would have to show that the relationship between multifidi and lower extremity MFI is a better indicator than multifidi MFI on its own. This can be grossly assessed by adding the two tests discussed in the next points.

OUR ANSWER: We apologize for unclear phrasing in the introduction. We understand the interpretation of us claiming inclusion of whole-body scans for diagnostic purposes, but this was not our intention. It was rather to communicate that studies involving whole-body scans can provide valuable information and knowledge in order to understand the mechanism behind fat infiltration in the multifidi muscles and why some individuals never fully recover from a whiplash trauma. We have now revised parts of the introduction to avoid the risk of such misinterpretation. We have also re-written the statistic section, the result and the discussion to bring more clarity regarding the suggested tests, please see our responses on points 2-4 below.

2. Results: Please perform an ANCOVA on your three regressions to determine whether the slopes are significantly different.

OUR ANSWER: In this study we used three different mixed linear models. In models B and C, group was included as a factor. In both these models, group differences were significant. This was unfortunately not clearly stated in the result section earlier. We have also made some changes in the discussion, conclusion and in our abstract based on comment 1-3 where we also emphasize the implications of a local injury more prominently than in the earlier version of this manuscript.

3. Results: Please also include an ANOVA on the multifidi MFI between groups to complement Figure 4.

OUR ANSWER: An ANOVA was already performed to complement Figure 4. We changed the wording in the result section to present it more distinctly.

Changes made: We replaced “The difference in the lower extremities’ MFI between the groups was not statistically significant (p = 0.11)” with “The ANOVA showed no statistically significant differences (p=0.11) in the lower extremities’ MFI between the different groups”

4. Results: Please report all statistical results in your Results section. The Discussion discusses associations between multifidi MFI and age, BMI and duration since injury and a comparison of multifidi MFI across groups. If these are outcomes of the statistical models, please include more details about the models and their outputs so the reader is aware of the results before the discussion.

OUR ANSWER: We realize that we have lacked in clarity in presenting our statistical analyses. In the statistic part of the method section we have addressed the different statistical models including ANOVA of the group measurements and the three different variations of the mixed linear models, which included variations of WAD group, age, BMI. A test of MFI versus Duration in the two WAD groups is also explained in that section. We have also improved consistency regarding the wording throughout the method, result and discussion to minimize miscommunication with a potential reader regarding which statistical analyses that have been performed.

5. Discussion: Please discuss additional explanations for the association between multifidi and lower extremity MFI. These are mentioned in the Introduction, but I would like to see a more in-depth treatment in the Discussion. “However, a number of hypotheses around injury severity, pain intensity and/or related disability (9, 10), heightened stress-responses (11-13) central/peripheral neuronal interference (14-16), and/or physical inactivity (17, 18) may be offered to explain the rapid expression and larger magnitude of MFI in patients with more severe self-reported symptoms.”

OUR ANSWER: We have added a reference suggested by reviewer 2 and also extended the discussion (paragraph 3 in the discussion) with a more detailed discussion of what the findings of this study might imply.

Reviewer #2:

Thank you for the opportunity to review this interesting manuscript for PLOS ONE. Our author colleagues have undertaken a study examining the relationship between cervical multifidus MFI and lower limb MFI in controls, mild WAD and mod-severe WAD patients. Findings indicate a relationship between cervical muscle MFI and lower limb MFI in mod-severe WAD patients.

General comments:

This study provides important insight on the mechanisms underpinning chronic WAD, which I believe represents an advance in our knowledge of this challenging condition.

I see that the authors have already made substantial amendments to the manuscript in response to two prior reviewers’ comments. My impression is that they have adequately addressed prior reviewer concerns.

OUR ANSWER: Thank you for your time and suggestion on how to improve this manuscript further. Below you will find our responses to the comments.

Specific comments:

Abstract

1) “…to investigate the relation between fat infiltration…” awkward wording, suggest revise to ‘…relationship between…’

OUR ANSWER: Thank you. We have changed the wording in the abstract as suggested.

Introduction

2) Minor typographic error: “…whiplash from an motor vehicle collision.” Correct to ‘…a motor vehicle…’

OUR ANSWER: Thank you for noting the error. It has been corrected.

3) Paragraph 2: “…reporting lower levels of pain-related disability, those nominating full recovery, idiopathic neck pain, and healthy controls.” Suggest add citation to this paper here: Elliott et al. (2008). Fatty infiltrate in the cervical extensor muscles is not a feature of chronic, insidious-onset neck pain. Clin Radiol. 63, 681-687

OUR ANSWER: The suggested article is now cited in the manuscript at the suggested location in paragraph 2.

4) Paragraph 3: In line with the hypothesis around SCI in WAD, I suggest also mentioning the preliminary publication detailing magnetic resonance spectroscopic evidence of cord injury below, as a complementary study supporting this theory:

Elliott JM, Pedler AR, Cowin G, Sterling M, McMahon K. Spinal cord metabolism and muscle water diffusion in whiplash. Spinal Cord. 2012 Jun;50(6):474-6

OUR ANSWER: We added the potential effect of spinal cord injury with reference to this preliminary study in the third paragraph in introduction section.

Methods

5) “…technique uses foreground and backgrounds seeds and let the segmented mask grow.” Awkward wording, suggest revise.

OUR ANSWER: We have revised the sentence to remove the awkward wording and to improve clarity.

New sentence: “Shortly described, the technique uses an algorithm that calculates a segmentation based on a few manually defined foreground seeds (pixels within the region of interest) and background seeds (outside the region of interest).”

6) “The segmentation was performed by a musculoskeletal physiotherapist with >6 months experience.” Suggest slight re-wording for clarity that it is 6 months experience doing this particular analysis (or as applicable).

OUR ANSWER: This has now been clarified in the method section.

This is the new sentence: “The segmentation was performed by a musculoskeletal physiotherapist with more than 6 months experience doing this particular analysis.”

7) Statistics: Was there a power/sample size calculation undertaken?

OUR ANSWER: No, there was not. At the time for applying ethical approval and starting of the data acquisition, no reference literature measuring fat infiltration using fat- and water separation with age- and gender matched controls were found. In addition, literature has found indications that fat infiltration plays a role in WAD but estimating the smallest effect size that would be of scientific interest is still hard. However, we hope that with the evolved techniques around muscle fat infiltration with MR and the results from this study and others (e.g. Pedler et al 2018) will help in starting future studies with larger number of participants for further understanding of the mechanism of the whiplash trauma.

Discussion

8) The Discussion reads well. My only comment is that it would be good to address the contrasting findings between this study and that of Pedler et al (2018) which did not find increased lower limb MFI in WAD:

Pedler A, McMahon K, Galloway G, Durbridge G, Sterling M (2018) Intramuscular fat is present in cervical multifidus but not soleus in patients with chronic whiplash associated disorders. PLoS ONE 13(5):https://doi.org/10.1371/journal.pone.0197438

OUR ANSWER: Thank you for the suggestion. We have addressed the study by Pedler et. al both in the introduction (last paragraph before the aim) and in the discussion (paragraph 3) to help the potential reader to understand not only the contrasting findings but also the similarities in the findings.

Attachments
Attachment
Submitted filename: Response_to_Reviewers.docx
Decision Letter - Xi Chen, Editor

The relation between local and distal muscle fat infiltration in chronic whiplash using magnetic resonance imaging

PONE-D-19-19642R1

Dear Dr. Karlsson,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Xi Chen

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you to the authors for their revisions of the manuscript. They have appropriately addressed the comments that I raised in my earlier review.

My only minor comment is that there is a typographic error in the spelling of Shapiro in the first paragraph of the Statistics section of the Method.

Reviewer #3: Previous reviewer's comments were fully addressed by the authors. It has significant improvement over the previous version and would be suitable for publication in the current form.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Scott Farrell PhD

Reviewer #3: No

Formally Accepted
Acceptance Letter - Xi Chen, Editor

PONE-D-19-19642R1

The relation between local and distal muscle fat infiltration in chronic whiplash using magnetic resonance imaging

Dear Dr. Karlsson:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xi Chen

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .